QCG
SRTA

Quadrant Capital Group’s Strata Critical Medical Inc SRTA Stock Holding History

Quadrant Capital Group’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.3K Buy
+551
New +$2.65K ﹤0.01% 2487

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quadrant Capital Group's SRTA Position: Q1 2026 in Review

Quadrant Capital Group opened a new position in Strata Critical Medical Inc (SRTA) in Q1 2026: 551 shares worth $2.3K. The stake represents ﹤0.01% of the portfolio and ranks #2487 among its holdings.

125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Quadrant Capital Group held 551 shares of Strata Critical Medical Inc worth $2.3K as of Q1 2026.
  • Strata Critical Medical Inc was a new Quadrant Capital Group position in Q1 2026.
  • Strata Critical Medical Inc made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2487 holding.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.